Showing results (111-120 of 122) with videos related to
Sort By:
Pageof 13
Gastroenterologie Clinique Et Biologique|April 1, 1980
[Hepatitis due to ajmaline. Report of cases and review of the literature]E A Pariente, D Pessayre, M Bentata-Pessayre, et al.Pathologie-Biologie|January 1, 1997
[Research of type 1, 2 and 3 hepatitis C virus specific antibodies in relation to the viral genotype in chronically infected patients]S Castelain, G Duverlie, H Khorsi, et al.Journal of Hepatology|March 1, 1995
Serum secretory IgA and secretory component in patients with non-cirrhotic alcoholic liver diseasesE Seillès, M Rossel, D A Vuitton, et al.Journal of Hepatology|August 1, 1988
Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trialD Lebrec, T Poynard, J P Capron, et al.Journal of Hepatology|July 1, 1990
Ursodeoxycholic acid for primary sclerosing cholangitisO Chazouillères, R Poupon, J P Capron, et al.Hepatology (Baltimore, Md.)|May 1, 1984
A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final reportD Lebrec, T Poynard, J Bernuau, et al.Drugs|January 1, 1989
A randomised controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosisD Lebrec, T Poynard, J Bernuau, et al.Journal of Hepatology|July 1, 1997
Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patientsH Khorsi, S Castelain, A Wyseur, et al.Journal of Hepatology|January 1, 1986
The treatment of refractory ascites by the LeVeen shunt. A multi-centre controlled trial (57 patients)P Bories, D Garcia Compean, H Michel, et al.Gastroenterologie Clinique Et Biologique|October 1, 1983
[Nodular regenerative hyperplasia of the liver. Study of 15 cases and review of the literature]J P Capron, C Degott, J Bernuau, et al.Pageof 13